Host immune cells in local graft microenvironment

Host immune cells in the local graft microenvironment represent the collective population of recipient immune cells, such as T cells, B cells, and myeloid cells, that infiltrate a transplanted organ. This microenvironment is the critical site where the host's immune system recognizes donor alloantigens, leading to the activation of effector mechanisms that can result in graft rejection (Starzl et al., 1992, Nature). The interaction between these infiltrating cells and the graft's parenchymal and vascular cells determines the balance between immune-mediated injury and the development of transplant tolerance (Wood et al., 2012, Nature Reviews Immunology). Pharmacological intervention typically involves systemic or local immunosuppression to inhibit the activation and recruitment of these cells to prevent acute and chronic rejection (Halloran, 2004, New England Journal of Medicine). While not a single molecular target, this cellular milieu is the primary focus of transplant medicine, with therapies like calcineurin inhibitors and monoclonal antibodies designed to modulate its composition and activity. Monitoring the phenotype and density of these cells via biopsy remains a gold standard for diagnosing rejection and tailoring therapy (Mengel et al., 2007, American Journal of Transplantation).

Other names

Graft-infiltrating leukocytesTransplant-infiltrating immune cellsIntragraft immune cell populationLocal graft immune microenvironment

Immunosuppressive agents target the local graft microenvironment by inhibiting T-cell receptor signaling, blocking co-stimulation, inhibiting nucleotide synthesis, or antagonizing cytokine receptors to prevent the recruitment and activation of host immune cells against the graft.